# \[e-drug\] Pharmaceutical industry funding of clinical research

**URL:** <https://talk.edrugplus.org/t/e-drug-pharmaceutical-industry-funding-of-clinical-research/21090>\
**Category:** e-drug\
**Created:** [November 25, 2004, 4:33am UTC](https://talk.edrugplus.org/t/e-drug-pharmaceutical-industry-funding-of-clinical-research/21090 "2004-11-25T04:33:58Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![joel.lexchin](https://avatars.discourse-cdn.com/v4/letter/j/e9c0ed/32.png) [@joel.lexchin](https://talk.edrugplus.org/u/joel.lexchin)\
**Post date:** [November 25, 2004, 4:33am UTC](https://talk.edrugplus.org/t/e-drug-pharmaceutical-industry-funding-of-clinical-research/21090/1 "2004-11-25T04:33:58Z")

</div>

E-DRUG: Pharmaceutical industry funding of clinical research  
------------------------------------------------------------

dear E-druggers,

I have written an article on the implications of pharmaceutical industry  
funding of clinical research which will be appearing in the January issue of  
the Annals of Pharmacotherapy. The journal posts articles on its web site in  
advance of their appearing in print and my piece has just been posted today.

Unfortunately, without a subscription you cannot download the article. I  
have a pdf version of the article and anyone who wants a copy can contact me  
personally and I'll be happy to send one electronically. I've put the  
abstract of the piece below:

This commentary explores the influence of industry funding and offers  
suggestions for overcoming some of the problems. First, it is difficult to  
obtain funding from some sources for research with limited commercial value.  
Second, lack of communication among researchers can impede scientific  
progress. Stopping research before meaningful results are available is  
another area of concern. Next, suppressed or delayed publication of data may  
bias the results of meta-analyses, resulting in incorrect risk-benefit  
profiles for drugs. Finally, commercially funded clinical research is more  
likely to yield positive results than when funding comes from other sources.  
Possible solutions are explored.

Joel Lexchin  
--  
Joel Lexchin MD  
121 Walmer Rd.  
Toronto ON  
Canada M5R 2X8  
Tel: 416-964-7186  
Fax: 416-923-9515  
E mail: joel.lexchin@utoronto.ca
